Angela Cenci Nilsson
131 – 140 of 160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
- Contribution to journal › Letter
-
Mark
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
- Contribution to journal › Article
- 2005
-
Mark
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
- Contribution to journal › Article
-
Mark
Chapte B7 - Utility of 6-hydroxydopamine lesioned rats in the preclinical screening of novel treatments for Parkinson disease
(2005) p.193-208
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
- Contribution to journal › Article
-
Mark
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
- Contribution to journal › Article
- 2004
-
Mark
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism
- Contribution to journal › Article
-
Mark
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
- Contribution to journal › Article
